At the Seventh Annual Health Law Year in P/Review symposium, leading experts discussed major developments during 2018 and what to watch out for in 2019. Speakers covered hot topics including health policy under the current administration, pharmaceutical policy, and public health law. Featured panels explored “Challenges Facing Health Care General Counsels” and “AI in Health Care.”
The conference also featured a special Fireside Chat with Stacy Cline Amin, Chief Counsel for the U.S. Food and Drug Administration.
Administration’s Guidance on State Innovation Waivers under the ACA Violates the Act’s Statutory Guardrails